Company profile BMY

Bristol-Myers Squibb Co.
The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the worlds largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.
Quarter analysis & expected interestLast update: February 08 2024 17:06:40.

After 39 days of this quarter the interest is at 223.0. Based on that we can calculate that during remaining 52 days it will total up to 520.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
2019434
652
50.2% QoQ
644
-1.2% QoQ
661
2.6% QoQ
2020 815
87.8% YoY 23.3% QoQ
851
30.5% YoY 4.4% QoQ
805
25.0% YoY -5.4% QoQ
692
4.7% YoY -14.0% QoQ
2021 525
-35.6% YoY -24.1% QoQ
518
-39.1% YoY -1.3% QoQ
462
-42.6% YoY -10.8% QoQ
505
-27.0% YoY 9.3% QoQ
2022 590
12.4% YoY 16.8% QoQ
554
6.9% YoY -6.1% QoQ
473
2.4% YoY -14.6% QoQ
374
-25.9% YoY -20.9% QoQ
2023 434
-26.4% YoY 16.0% QoQ
387
-30.1% YoY -10.8% QoQ
392
-17.1% YoY 1.3% QoQ
548
46.5% YoY 39.8% QoQ
2024 223
-48.6% YoY -59.3% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Bristol-Myers Squibb search interestLast update: February 08 2024 17:06:39.
Correlation coefficient between keyword and revenue is -0.21
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 17:06:41.

The average 5 years interest of Bristol-Myers Squibb was 44.21 per week.
The last year interest of Bristol-Myers Squibb compared to the last 5 years has changed by -20.49%.
The interest for Bristol-Myers Squibb is significantly decreasing.
The last year interest is quite lower compared to 5 years ago. It has decreased by -32.75%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 17:06:45.

After 39 days of this quarter the interest is at 460.0. Based on that we can calculate that during remaining 52 days it will total up to 1073.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
2019516
840
62.8% QoQ
870
3.6% QoQ
859
-1.3% QoQ
2020 896
73.6% YoY 4.3% QoQ
751
-10.6% YoY -16.2% QoQ
879
1.0% YoY 17.0% QoQ
920
7.1% YoY 4.7% QoQ
2021 1035
15.5% YoY 12.5% QoQ
1021
36.0% YoY -1.4% QoQ
1054
19.9% YoY 3.2% QoQ
1049
14.0% YoY -0.5% QoQ
2022 1192
15.2% YoY 13.6% QoQ
1050
2.8% YoY -11.9% QoQ
1131
7.3% YoY 7.7% QoQ
1106
5.4% YoY -2.2% QoQ
2023 1192
0.0% YoY 7.8% QoQ
1170
11.4% YoY -1.8% QoQ
1149
1.6% YoY -1.8% QoQ
1246
12.7% YoY 8.4% QoQ
2024 460
-61.4% YoY -63.1% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Eliquis search interestLast update: February 08 2024 17:06:45.
Correlation coefficient between keyword and revenue is 0.74
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 17:06:47.

The average 5 years interest of Eliquis was 78.11 per week.
The last year interest of Eliquis compared to the last 5 years has changed by 14.77%.
The interest for Eliquis is stable and increasing in the last 5 years.
The last year interest is quite higher compared to 5 years ago. It has increased by 34.51%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 17:06:51.

After 39 days of this quarter the interest is at 33.0. Based on that we can calculate that during remaining 52 days it will total up to 77.0.
Opdivo cancer treatment expected interest is significantly higher compared to same quarter last year (+250.0%) but lower than previous quarter (-51.9%).

YearQ1Q2Q3Q4
2019139
290
108.6% QoQ
253
-12.8% QoQ
91
-64.0% QoQ
2020 89
-36.0% YoY -2.2% QoQ
109
-62.4% YoY 22.5% QoQ
248
-2.0% YoY 127.5% QoQ
121
33.0% YoY -51.2% QoQ
2021 38
-57.3% YoY -68.6% QoQ
172
57.8% YoY 352.6% QoQ
121
-51.2% YoY -29.7% QoQ
32
-73.6% YoY -73.6% QoQ
2022 111
192.1% YoY 246.9% QoQ
186
8.1% YoY 67.6% QoQ
252
108.3% YoY 35.5% QoQ
193
503.1% YoY -23.4% QoQ
2023 22
-80.2% YoY -88.6% QoQ
96
-48.4% YoY 336.4% QoQ
193
-23.4% YoY 101.0% QoQ
160
-17.1% YoY -17.1% QoQ
2024 33
50.0% YoY -79.4% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Opdivo cancer treatment search interestLast update: February 08 2024 17:06:51.
Correlation coefficient between keyword and revenue is -0.39
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 17:06:54.

The average 5 years interest of Opdivo cancer treatment was 11.3 per week.
The last year interest of Opdivo cancer treatment compared to the last 5 years has changed by -14.25%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -38.16%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 17:07:00.

After 39 days of this quarter the interest is at 53.0. Based on that we can calculate that during remaining 52 days it will total up to 124.0.
Bristol-Myers Squibb careers expected interest is significantly higher compared to previous quarter (+74.6%) and same quarter last year (+69.9%).

YearQ1Q2Q3Q4
201926
0
-100.0% QoQ
135
inf% QoQ
132
-2.2% QoQ
2020 105
303.8% YoY -20.5% QoQ
67
inf% YoY -36.2% QoQ
147
8.9% YoY 119.4% QoQ
83
-37.1% YoY -43.5% QoQ
2021 118
12.4% YoY 42.2% QoQ
63
-6.0% YoY -46.6% QoQ
0
-100.0% YoY -100.0% QoQ
64
-22.9% YoY inf% QoQ
2022 127
7.6% YoY 98.4% QoQ
71
12.7% YoY -44.1% QoQ
78
inf% YoY 9.9% QoQ
16
-75.0% YoY -79.5% QoQ
2023 73
-42.5% YoY 356.2% QoQ
67
-5.6% YoY -8.2% QoQ
157
101.3% YoY 134.3% QoQ
71
343.8% YoY -54.8% QoQ
2024 53
-27.4% YoY -25.4% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Bristol-Myers Squibb careers search interestLast update: February 08 2024 17:06:59.
Correlation coefficient between keyword and revenue is 0.06
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 17:07:00.

The average 5 years interest of Bristol-Myers Squibb careers was 6.33 per week.
The last year interest of Bristol-Myers Squibb careers compared to the last 5 years has changed by 5.69%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 18.83%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 17:07:04.

After 39 days of this quarter the interest is at 125.0. Based on that we can calculate that during remaining 52 days it will total up to 292.0.
Bristol-Myers Squibb -stock -company expected interest is significantly lower compared to previous quarter (-44.4%) but similar to same quarter last year.

YearQ1Q2Q3Q4
2019547
793
45.0% QoQ
736
-7.2% QoQ
594
-19.3% QoQ
2020 760
38.9% YoY 27.9% QoQ
696
-12.2% YoY -8.4% QoQ
743
1.0% YoY 6.8% QoQ
563
-5.2% YoY -24.2% QoQ
2021 410
-46.1% YoY -27.2% QoQ
436
-37.4% YoY 6.3% QoQ
352
-52.6% YoY -19.3% QoQ
402
-28.6% YoY 14.2% QoQ
2022 425
3.7% YoY 5.7% QoQ
496
13.8% YoY 16.7% QoQ
432
22.7% YoY -12.9% QoQ
245
-39.1% YoY -43.3% QoQ
2023 433
1.9% YoY 76.7% QoQ
325
-34.5% YoY -24.9% QoQ
389
-10.0% YoY 19.7% QoQ
525
114.3% YoY 35.0% QoQ
2024 125
-71.1% YoY -76.2% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Bristol-Myers Squibb -stock -company search interestLast update: February 08 2024 17:07:04.
Correlation coefficient between keyword and revenue is -0.61
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 17:07:05.

The average 5 years interest of Bristol-Myers Squibb -stock -company was 39.95 per week.
The last year interest of Bristol-Myers Squibb -stock -company compared to the last 5 years has changed by -22.08%.
The interest for Bristol-Myers Squibb -stock -company is significantly decreasing.
The last year interest is quite lower compared to 5 years ago. It has decreased by -46.0%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for BMY
Company name: Bristol-Myers Squibb Co.
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-05-14T12:30:00Z

BusinessWire
Tempus Expands Strategic Collaboration with Bristol Myers Squibb to Enhance the Probability of Success Across Clinical Development Programs In Oncology and Neuroscience

2026-05-12T20:01:00Z

GlobeNewswire
Pacira BioSciences Sends Letter to Stockholders Reiterating Superior Qualifications of its Board Nominees

2026-05-12T08:30:00-04:00

PR Newswire
Wall Street's Cardiac Bet: Where Diagnostics Meet the Money

2026-05-12T05:00:00.000Z

US FDA
Approval of Opdivo Qvantig, Bla #761381

2026-05-08T10:59:00Z

BusinessWire
Bristol Myers Squibb Receives European Commission Approval of Sotyktu (deucravacitinib) for the Treatment of Active Psoriatic Arthritis in Adults

2026-05-06T10:59:00Z

BusinessWire
Bristol Myers Squibb to Participate in the Bank of America Securities Healthcare Conference 2026

2026-05-05T10:51:06.186Z

Reuters
Pfizer pins post 2028 return to growth on new obesity and cancer drugs

2026-05-04T10:59:00Z

BusinessWire
Bristol Myers Squibb Launches "Won't Lose" Media Campaign Ahead of FIFA World Cup 2026™

2026-05-01T14:03:53.903Z

Reuters
Big Pharma M&A set for mega year as patent expiries drive deal urgency

2026-04-30T11:46:08Z

Analyst Upgrades
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields

2026-04-30T11:01:12.256Z

Reuters
Bristol Myers beats quarterly profit estimates on blood thinner, cancer drug sales

2026-04-30T10:59:00Z

BusinessWire
Bristol Myers Squibb Reports First Quarter Financial Results for 2026

2026-04-27T12:22:02+0000

CNBC
WHCD shooting, DOJ ends Powell probe, Musk vs. Altman and more in Morning Squawk

2026-04-24T10:59:00Z

BusinessWire
Bristol Myers Squibb and Pfizer to Make Eliquis® (apixaban) Available via Mark Cuban Cost Plus Drug Company

2026-04-23T08:00:00-04:00

PR Newswire
Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration